Max Healthcare Institute Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹1,910Cr
- +34.2% YoY
- +2.2% QoQ
- Net profit
- ₹319Cr
- +26.6% YoY
- +33.5% QoQ
- Margin
- 27%
- 0 pp YoY
- 0 pp QoQ
Guidance rank: #7 of 34 in Healthcare Services
See the sector's top 10 — free with your mobile number.
The short version
Max Healthcare expects strong growth driven by recent acquisitions (Lucknow, Nagpur, Jaypee Noida) and new facilities (Dwarka, brownfield expansions). Strong earnings and EBITDA growth expected driven by capacity expansion and acquisitions.
From Max Healthcare Institute Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Max Healthcare expects strong growth driven by recent acquisitions (Lucknow, Nagpur, Jaypee Noida) and new facilities (Dwarka, brownfield expansions).
- FY '25 revenue saw a 26% YoY growth and 22% growth in EBITDA.
- New brownfield expansions adding around 1,500 beds in FY '26 are expected to ramp up quickly, improving occupancy and margins.
- Greenfield projects like Gurgaon will take longer to mature but contribute incremental revenue over time.
- Average Revenue Per Occupied Bed (ARPOB) is growing (~7% YoY growth in existing hospitals).
- Increased institutional and international business will contribute, though international patients may not move the needle significantly at new locations initially.
2 more points from Max Healthcare Institute Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Max Healthcare Institute Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Max Healthcare is undertaking multiple expansion projects:
- 268 beds at Nanavati (Phase I) with commissioning expected within 90 days.
- 155 beds at Mohali with commissioning also expected within 90 days; plans to add 45 more beds post-tower completion.
- A built-to-suit hospital in Gurgaon (Sec-56) to be completed by end of calendar year.
- Brownfield expansions at Max Smart and other locations adding approximately 1,500 beds in FY '26.
- 18 acres of land in Noida with potential to add 1,000+ beds; current occupancy at 50%.
- Land acquisition of around 1 acre adjacent to fully occupied Vaishali hospital; brownfield expansion expected within 30 months.
2 more points from Max Healthcare Institute Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Max Healthcare Institute Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- It does detail ongoing and upcoming expansion projects including:
- 397 beds at Patparganj with environmental clearance and tendering underway.
- 550 beds at Max Vikrant (Saket Complex) pending forest department clearance, expected completion by 2028.
- 400 beds at Zirakpur (Mohali), awaiting environmental clearance, with a 30-month completion timeline.
- 140 beds at Vaishali brownfield project planned, expected completion within 30 months.
- The company plans to add around 1,500 beds in FY26 through brownfield expansions and greenfield projects like Nanavati (268 beds), Mohali (155 beds), Max Smart, and Gurgaon Sec-56.
2 more points from Max Healthcare Institute Ltd's call on order book
Create a free account to keep reading this call
Max Healthcare Institute Ltd — Quarterly revenue & net profit
Max Healthcare Institute Ltd Q4 FY25 results — key figures
| ₹ Cr | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue | 1,910 | 1,423 | +34.2% | 1,868 | +2.2% |
| Operating profit (EBITDA) | 512 | 382 | +34% | 499 | +2.6% |
| Operating margin | 27% | 27% | 0 pp | 27% | 0 pp |
| Profit before tax | 402 | 336 | +19.6% | 309 | +30.1% |
| Net profit (PAT) | 319 | 252 | +26.6% | 239 | +33.5% |
| EPS (₹) | 3.28 | 2.59 | +26.6% | 2.46 | +33.3% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.6K Cr, net profit ₹414 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Max Healthcare's management said in earlier quarters
Others in Healthcare Services this season
- 3B Blackbio (Q4 FY25)
UK subsidiary (TRUPCR Europe Limited) revenue FY 2024-25: GBP 1,287,580, a 94% increase over FY 2023-24 GBP 664,059. Key concall takeaways from 3B Blackbio DX…
- Apollo Hospitals (Q4 FY25)
. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
- Shalby (Q4 FY25)
Implant business is in high-growth mode: 4x growth in Indonesia, 35-40% growth in U.S., and 2.5x growth in India reported last year. Key concall takeaways from…
- Narayana Hrudaya (Q4 FY25)
Capex is split between regular maintenance/replacement (~INR 300 crores) and new greenfield/brownfield capacity (~INR 450 crores) with some variability based…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Max Healthcare Institute Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Max Healthcare Institute Ltd Q4 FY25 results?
Max Healthcare expects strong growth driven by recent acquisitions (Lucknow, Nagpur, Jaypee Noida) and new facilities (Dwarka, brownfield expansions). Strong earnings and EBITDA growth expected driven by capacity expansion and acquisitions.
What is Max Healthcare Institute Ltd share price analysis?
Max Healthcare Institute Ltd currently shows a neutral. The stock trades at a P/E of 65.6 with a market cap of ₹98,161 Cr. Investors should review the full earnings analysis for detailed insights.
Is Max Healthcare Institute Ltd planning capital expenditure?
Max Healthcare is undertaking multiple expansion projects: - 268 beds at Nanavati (Phase I) with commissioning expected within 90 days.
Keep Max Healthcare Institute Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
